Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options (Q42986593)
Jump to navigation
Jump to search
scientific article published on 23 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options |
scientific article published on 23 November 2012 |
Statements
1 reference
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options (English)
1 reference
Kazuaki Chayama
1 reference
Yoshiiku Kawakami
1 reference
Hiromitsu Kumada
1 reference
Fumitaka Suzuki
1 reference
Kenji Ikeda
1 reference
Yoshiyuki Suzuki
1 reference
Joji Toyota
1 reference
Yoshiyasu Karino
1 reference
Hiroki Ishikawa
1 reference
Hideaki Watanabe
1 reference
Wenhua Hu
1 reference
Timothy Eley
1 reference
Fiona McPhee
1 reference
Eric Hughes
1 reference
23 November 2012
1 reference
1 reference
Identifiers
1 reference